BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Upstream Biosciences Inc. Appoints Dr. Michael Hayden Killam Professor of Medical Genetics and the Canada Research Chair in Human Genetics to Its Scientific Advisory Board


10/1/2008 9:29:24 AM

VANCOUVER, BC--(Marketwire - October 01, 2008) - Upstream Biosciences Inc. (OTCBB: UPBS) today announced the appointment of Dr. Michael Hayden, MD, PhD, FRCPC to its Scientific Advisory Board (SAB). Dr. Hayden has co-founded three companies: Xenon Pharmaceuticals, Aspreva Pharmaceuticals Inc., and Neurovir. He is currently serving as chief scientific officer for Xenon and chairman of the medical advisory board for Aspreva. Aspreva focuses on repurposing existing drugs to treat rare diseases and was purchased in a deal worth approximately $915 million US by the Galenica Group. Dr. Hayden is a full professor of Medical Genetics at the University of British Columbia as well as Director of the Center for Molecular Medicine and Therapeutics (CMMT) in Vancouver; the CMMT is a gene research center under UBC's Faculty of Medicine.

Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES